Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis

ClinicalTrials.gov ID: NCT01241214

Public ClinicalTrials.gov record NCT01241214. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 4:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Double-blind, Randomized, Placebo-controlled, Active Reference, Parallel-group, Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will assess the efficacy and safety of different doses of ACT-129968 in adult patients with seasonal allergic rhinitis, due to mountain cedar pollen.

Study identification

NCT ID
NCT01241214
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Idorsia Pharmaceuticals Ltd.
Industry
Enrollment
579 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2010
Primary completion
Jan 31, 2011
Completion
Jan 31, 2011
Last update posted
May 14, 2019

2010 – 2011

United States locations

U.S. sites
7
U.S. states
1
U.S. cities
4
Facility City State ZIP Site status
Clinical Investigative Site 7905 Austin Texas 78731
Clinical Investigative Site 7907 Kerrville Texas 78028
Clinical Investigative Site 7903 New Braunfels Texas 78130
Clinical Investigative Site 7901 San Antonio Texas 78229
Clinical Investigative Site 7902 San Antonio Texas 78229
Clinical Investigative Site 7904 San Antonio Texas 78229
Clinical Investigative Site 7906 San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01241214, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2019 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01241214 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →